{
  "source_pdf": "data/clinical_files/Zimmerman et al. (2023).pdf",
  "blocks": [
    {
      "id": "308766f1",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        1132.62744140625,
        1917.3895263671875,
        3111.271484375,
        2869.70654296875
      ],
      "text": "uite 600 Schenley Place, 4420 Bayard St., Pittsburgh, PA 15260, USA n of Infectious Diseases/Pharmacy Department – AMP 5TH Floor Falk Medical Building, 3601 Fifth Ave, Pittsburgh, PA a b s t r a c t Background: Relative effectiveness of various vaccine formulations provide important input for vaccine policy decisions and provider purchasing decisions. We used electronic databases to conduct a test- negative case control study to determine relative vaccine effectiveness (rVE) of recombinant inﬂuenza vaccine (RIV4) compared with standard dose vaccines (SD-IIV4) against inﬂuenza hospitalization. Methods: Adults 18–64 and \u000165 years of age hospitalized in a large U.S. health system (19 hospitals) in 2018-2019 and 2019-2020 who were clinically tested for inﬂuenza using reverse transcription poly- merase chain reaction (RT-PCR) as says were included. The hospital system electronic medical record (EMR) and the state immunization registry were used to conﬁrm inﬂuenza vaccination. Propensity scores with inverse probability weighting were used to adjust for potential con founders and determine rVE. Results: Of the 14 590 individuals included in the primary analysis, 3,338 were vaccinated with RIV4 and 976 were vaccinated with SD-IIV4, with the balance of 10 276 being unvaccinated. Most participants",
      "metadata": {
        "score": 0.9629931449890137,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.002499103546142578,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "a1cb3909",
      "page_index": 0,
      "role": "Figure",
      "bbox": [
        226.28167724609375,
        348.6789855957031,
        3095.326416015625,
        891.0459594726562
      ],
      "text": "[FIGURE 1 - See figure_p1_a1cb3909.png]",
      "image_path": "figures/figure_p1_a1cb3909.png",
      "metadata": {
        "score": 0.9660476446151733,
        "detection_dpi": 400
      }
    },
    {
      "id": "8fc45971",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        1694.8577880859375,
        3179.256591796875,
        3093.532958984375,
        3925.0439453125
      ],
      "text": "standard dose inﬂuenza ization using a retrospective ine sevier.com/locate/vaccine",
      "metadata": {
        "score": 0.9890636801719666,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00030803680419921875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "b4e28b86",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        183.31378173828125,
        975.7985229492188,
        2687.689208984375,
        1277.03759765625
      ],
      "text": "1. Introduction Despite the availability of an array of inﬂuenza vaccines and recommendations for vaccination of individuals age 6 months and over, inﬂuenza remains a major cause of m izations and mortality in the U.S. and worldw 1–2 decades, effectiveness of egg based stand vaccine has been modest [1–5]. New inﬂuenz",
      "metadata": {
        "score": 0.9933744072914124,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006411075592041016,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ed8bd334",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        205.0552215576172,
        1475.74609375,
        3005.108154296875,
        1692.583984375
      ],
      "text": "Conclusions: Over all adults, both RIV4 and SD-IIV4 were effective against inﬂuenza hospitalization, RIV4 providing better protection compared with SD-IIV4 overall, for females, younger adults, and t with no high risk conditions. \u0001 2023 Else vier Ltd. All rights rese",
      "metadata": {
        "score": 0.9974738955497742,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00047588348388671875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "60d1eb27",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        207.20448303222656,
        3510.2255859375,
        1612.1533203125,
        3945.560546875
      ],
      "text": "Va journal homepage: www",
      "metadata": {
        "score": 0.9958498477935791,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00008392333984375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "6ce8cb81",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        212.29185485839844,
        3312.8720703125,
        1618.2657470703125,
        3450.0595703125
      ],
      "text": "Vaccine effectiveness of recombinant and i i t i ﬂ l t d h it",
      "metadata": {
        "score": 0.9575923681259155,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00009083747863769531,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "532a4b79",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        197.9965362548828,
        3192.501708984375,
        553.3158569335938,
        3273.58203125
      ],
      "text": "vaccines a test negat",
      "metadata": {
        "score": 0.9491482973098755,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00003910064697265625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "80bc60b3",
      "page_index": 0,
      "role": "Title",
      "bbox": [
        1113.87451171875,
        1804.523681640625,
        1494.3228759765625,
        1878.423828125
      ],
      "text": "were white (80 %), 65 years or older (",
      "metadata": {
        "score": 0.9338405132293701,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.000028133392333984375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "055177cc",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        226.89292907714844,
        1299.824462890625,
        3060.946533203125,
        1462.4417724609375
      ],
      "text": "",
      "metadata": {
        "score": 0.8423539400100708,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "697b239f",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        2328.2822265625,
        2876.483154296875,
        3106.5986328125,
        2940.267822265625
      ],
      "text": "",
      "metadata": {
        "score": 0.7315871715545654,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "6bf7c6eb",
      "page_index": 0,
      "role": "List",
      "bbox": [
        193.25204467773438,
        4047.74755859375,
        1089.6387939453125,
        4159.8212890625
      ],
      "text": "",
      "metadata": {
        "score": 0.6052444577217102,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "68b01457",
      "page_index": 0,
      "role": "Text",
      "bbox": [
        262.0503845214844,
        3959.45166015625,
        1210.9000244140625,
        4016.239990234375
      ],
      "text": "",
      "metadata": {
        "score": 0.5893712639808655,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "206246cf",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        205.23043823242188,
        324.81512451171875,
        1612.786865234375,
        1336.697998046875
      ],
      "text": "2.1. Patients Patients were individuals 18 years and older as of August 1 each season who were hospitalized in one of nineteen UPMC hospitals in central and southwestern Pennsylvania and had a test for inﬂu- enza at any time between 11 01 2018 and 04 30 2020. A Ther- adoc\u0003 database (an infection control software) was used to identify those tested for inﬂuenza using reverse transcription poly- merase chain reaction (RT-PCR) as says performed in a centralized clinical lab for some hospitals and individual hospital labs for others. Inﬂuenza cases were those who tested positive for inﬂu- enza and controls were those who tested negative for inﬂuenza, regardless of any other identiﬁed viral infection. Both the EMR and Pennsylvania Statewide Immunization Information System (PA-SIIS) were queried for inﬂuenza vaccines given between August 1 and the date of illness/PCR testing. Exclusion criteria were testing within 2 weeks of vaccination, having 2 different types of",
      "metadata": {
        "score": 0.9941837191581726,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0015151500701904297,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "a788eecc",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        203.46017456054688,
        3191.06396484375,
        1603.8377685546875,
        4203.201171875
      ],
      "text": "Reasonably accurate VE and relative VE (rVE) estimates depend upon having access to a sufﬁcient number of recipients of any given vaccine type. Research on high dose quad rival ent inﬂuenza vaccine (HD-IIV4) has reported rVE for HD-IIV4 compared with standard dose quad rival ent inﬂuenza vaccine (SD-IIV4) of 24 % against laboratory-conﬁrmed inﬂuenza [7] and 27 % against inﬂu- enza hospitalization [8]. Several studies of cell cultured inﬂuenza vaccine were conducted prior to the 2019-2020 season (when all four vaccine strains were cell cultured and have not shown sign if icant rVE against inﬂuenza illness compared with SD-IIV4 [9]. A large retrospective study of Medicare bene cia ries (\u000165 years of age) in the 2019-2020 season demonstrated no sign i cant rVE of cell cultured quad rival ent inﬂuenza vaccine (ccIIV4) compared with SD-IIV4 against inﬂuenza-related hospital encounters [10]. However the study was limited by the fact that there were no R. K. Zimmerman, M. Patricia No walk, K. Dauer et al.",
      "metadata": {
        "score": 0.9928391575813293,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.001711130142211914,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "4958fbac",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1698.413818359375,
        464.55877685546875,
        3107.420654296875,
        1438.642578125
      ],
      "text": "p each tree in the model, allowing for three way interactions among all covariates to be considered. The shrinkage parameter was set to 0 0005 to ensure a smooth ﬁt. We also checked the balance of all the variables included in the model to assess the quality of the propensity score and evaluate common support, using a value under 0.25 as indicative of good balance. We also used the balance plots to compare the propensity score distributions and to evaluate the common support. Using the propensity score, we calculated the inverse pro babil ity of receiving SD-IIV4 weighting. In this approach, for an individ- ual receiving SD-IIV4 t, the weight equals 1=ptðxÞ , where ptðxÞ is the propensity score (probability that an individual with character- is tics x receives SD-IIV4 t). A propensity score weighted logistic regression with inﬂuenza status as the dependent variable was ﬁt- ted to estimate the effect of vaccine (SD-IIV4 vs. RIV4) on outcome and also used inverse probability weighting to estimate VE and its 95 % conﬁdence intervals We added covariates like high risk con-",
      "metadata": {
        "score": 0.9938454031944275,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00145721435546875,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "7332f007",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1682.9224853515625,
        1491.3941650390625,
        3112.756103515625,
        2376.13427734375
      ],
      "text": "Standard Dose Flu zone and FlucelVax. HD IIV4 was High Dose Flu zone, RIV4 was Flublok and Adj-IV was FluAd. Other independent variables were age, inﬂuenza season (2018-2019 and 2019– 2020), sex, race and presence of one or more high risk conditions. Adjusted VE was calculated for RIV4, SD-IIV4 and combined RIV4, high dose, egg based and adjuvanted vaccines. Relative VE (rVE) was calculated as 1 minus the ratio of adjusted VE times 100 %. We conducted propensity adjustment analyses to reduce the potential impact of selection effects (i.e., confounding) on baseline characteristics. We estimated the propensity scores using the Gen- eralized Boosted Regression Models (GBM) approach, which is a non parametric model that allows for nonlinear relationships with a maximum number of iterations set to the default (i.e.,10,000) that minimized the balance statistics of interest. We used the bal- ance statistic based on absolute standardized bias (also referred as the effect size or absolute standardized mean difference) and sum-",
      "metadata": {
        "score": 0.9971103668212891,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0015387535095214844,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ea78cbe6",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1692.1217041015625,
        3454.068603515625,
        3107.534912109375,
        4237.7861328125
      ],
      "text": "2.2. Statistical methods For primary analysis, all adults \u000118 years were included, then for secondary analyses, they were stratiﬁed into age groups \u000165 years, and 18–64 years. Sample size calculations deter- mined that we had 48 % power to detect an effect size of 9.5 % change from a baseline probability of 11.7 %. Post hoc sample size calculations for age subgroup analyses resulted in 42 % and 20 % power for ages 18–64 years and \u000165 years with effect sizes of 8.9 %, and 8.7 %, with the detectable difference of 3 % and 2.1 % Vaccine 41 (2023) 5134-5140",
      "metadata": {
        "score": 0.9935698509216309,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006279945373535156,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "22eb7506",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1686.9898681640625,
        2410.352294921875,
        3116.901611328125,
        3140.9521484375
      ],
      "text": "and percentages for categorical data. Baseline characteristics between the vaccination groups were compared using chi square or the Fisher’s exact tests for categorical variables and ages were compared by using t-test. Using adjusted odds ratios (aORs) obtained from multivariable logistic regression models, adjusted VE estimates were calculated as (1-aOR) X 100. The dependent variable of interest was inﬂuenza status. The primary exposure of interest was vaccine type (recom- bin ant, SD-IIV4s and in some analyses, enhanced vaccines such as HD-IIV4 and adjuvanted inﬂuenza vaccine (Adj-IV)). The CDC has recommended the use of ‘‘enhanced vaccines” for adults ages 65 and older beginning in 2022 [13]. Inﬂuenza vaccines were ident i ﬁed through the EMR; SD-IIV4 included A uri a, Fluarix, FluLaval,",
      "metadata": {
        "score": 0.9971029162406921,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0013151168823242188,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "79cbb5c4",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        191.58731079101562,
        1763.7620849609375,
        1605.28515625,
        2404.069580078125
      ],
      "text": "bidity and mortality. Additional rVE studies of new vaccine formu- lat ions are needed to help determine vaccination best practices. This study is a retrospective test negative case control study of inﬂuenza VE against hospitalization using data from electronic medical records (EMR) of a single large health system to determine the rVE of RIV4 among adults 18–64 and \u000165 years of age in the 2018-2019 and 2019-2020 seasons. 2. Methods The University of Pittsburgh Institutional Review Board",
      "metadata": {
        "score": 0.9949571490287781,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0010709762573242188,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "8467ff67",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        206.67095947265625,
        2586.046630859375,
        1611.9993896484375,
        3024.283203125
      ],
      "text": "Two large studies have explored rVE of recombinant quad riva lent inﬂuenza vaccine (RIV4). The Medicare bene cia ries study [10] using retrospective data as described above, reported sign i cant rVE of RIV4 vs. SD-IIV4) against inﬂuenza-related hospital encounters. Secondly, a randomized controlled trial (RCT) found sign i cant rVE of RIV4 compared with SD-IIV4 among adults \u000150 years old, but not for adults \u000165 years old [11]. Given the higher cost of newer vaccines, and the high risk of",
      "metadata": {
        "score": 0.9859206080436707,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0007228851318359375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "855b3df8",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        196.11691284179688,
        1369.2188720703125,
        1616.7529296875,
        1734.955078125
      ],
      "text": "approved this retrospective study using EMR databases. A test- negative case control study estimates VE by comparing the odds of vaccination among patients hospitalized with inﬂuenza like ill- ness with conﬁrmed inﬂuenza to the odds of vaccination among controls, i.e., patients hospitalized with inﬂuenza like illness who tested negative for inﬂuenza.",
      "metadata": {
        "score": 0.9956953525543213,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0005617141723632812,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "8737e17e",
      "page_index": 1,
      "role": "Text",
      "bbox": [
        1697.7811279296875,
        3165.93212890625,
        3108.697265625,
        3429.450927734375
      ],
      "text": "respectively, thus these analyses were likely to be underpowered to detect a sign i cant rVE for RIV4 over SD-IIV4. Moreover, rVE estimates by vaccine strain were also precluded by insufﬁcient sample sizes. Descriptions of variables for each group were sum- mari zed as mean and standard deviation for age and frequencies",
      "metadata": {
        "score": 0.9903292655944824,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0004980564117431641,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "46cc96cd",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        195.0945281982422,
        2484.75341796875,
        465.6174621582031,
        2563.85009765625
      ],
      "text": "inﬂuenza co [12], there i",
      "metadata": {
        "score": 0.9949945211410522,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00005602836608886719,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "e8131896",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        195.5936737060547,
        3089.89892578125,
        467.0396728515625,
        3168.64453125
      ],
      "text": "laboratory-c of cell cultur",
      "metadata": {
        "score": 0.986190915107727,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00010800361633300781,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "7345b0ed",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        1682.7359619140625,
        359.9187927246094,
        2181.47119140625,
        435.2266540527344
      ],
      "text": "ditions and inﬂuenza se ing a good balance for t",
      "metadata": {
        "score": 0.9813862442970276,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00009012222290039062,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "af96fe48",
      "page_index": 1,
      "role": "Title",
      "bbox": [
        184.7032012939453,
        249.44656372070312,
        1076.163330078125,
        316.5755310058594
      ],
      "text": "inﬂuenza vaccine in a season, missing an i f ti d h i i",
      "metadata": {
        "score": 0.3063209354877472,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00008606910705566406,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "41870911",
      "page_index": 2,
      "role": "Figure",
      "bbox": [
        315.69525146484375,
        2874.55322265625,
        2885.017333984375,
        4076.7021484375
      ],
      "text": "[FIGURE 8 - See figure_p3_41870911.png]",
      "image_path": "figures/figure_p3_41870911.png",
      "metadata": {
        "score": 0.9968260526657104,
        "detection_dpi": 400
      }
    },
    {
      "id": "29672a8c",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1688.9136962890625,
        1368.252685546875,
        3105.4248046875,
        2267.343017578125
      ],
      "text": "adults \u000165 years. Again, having a high risk condition was as soci ated with receipt of one of these vaccines (87.5 % combined vs. 78.4 % SD-IIV4; P < 0 001. Adjusted VEs for RIV4 for younger adults were sign i cant across all subgroups, whereas, VE for SD-IIV4 was sign i cant for males only. Among older adults, VE of RIV4 was sign i cant for females (47 %; 95 % CI = 30, 60) but not males (\u00032 %; 95 % CI = –33, 21) or for those with and without high risk conditions. VEs for those \u000165 years old receiving RIV4, HD-IV4 or Adj-IV showed sim- ilar patterns of signiﬁcance across subgroups (overall VE = 24 %; 95 % CI = 11, 36; females VE = 38 %; 95 % CI = 22, 51); high risk",
      "metadata": {
        "score": 0.9974564909934998,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0008461475372314453,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "caa70ae4",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        196.02984619140625,
        1713.516357421875,
        1609.8021240234375,
        2620.15869140625
      ],
      "text": "The total number of inﬂuenza test results among inpatients was 18 467 of which 530 were excluded because of missing vaccination information or vaccination < 14 days before illness, and 3,264 were excluded from the primary analyses because patients were immunocompromised or received enhanced vaccines other than RIV4 (n = 613), leaving 14 590 for the primary analysis (Fig. 1). Of these, 3,338 were vaccinated with RIV4 and 976 were vacci- nated with SD-IIV4, with the balance of 10 276 being unvaccinated. For the secondary analyses, the analyzable cohort included the 613 HD-IIV4 and Adj-IV recipients bringing the total analyzable sample to 15 203 (Fig. 2). The inﬂuenza positivity rate was 12.4 % (1 803 14 590 overall, 14.4 % among younger adults 18–64 years and 11.1 % (922 8306 among those \u000165 years, with the addition of 613 patients who received enhanced vaccines that were not included in the primary analysis. Demographic characteristics of the population for the primary anal ses are sho n in Table 1; most participants ere hite",
      "metadata": {
        "score": 0.9922518134117126,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.001683950424194336,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "566c806c",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1690.316650390625,
        607.1668090820312,
        3113.547119140625,
        1321.5528564453125
      ],
      "text": "",
      "metadata": {
        "score": 0.9972039461135864,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "c20bb765",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        197.36695861816406,
        842.527099609375,
        1619.53125,
        1467.6412353515625
      ],
      "text": "",
      "metadata": {
        "score": 0.9918091893196106,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "f8bde505",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1694.413818359375,
        2297.56298828125,
        3116.84765625,
        2767.474853515625
      ],
      "text": "white race (83.7 % RIV4 vs. 71.8 % SD-IIV4; P < 0 001, fewer cases of inﬂuenza (9.2 % RIV4 vs. 11.9 % SD-IIV4; P < 0 041 and having a high risk condition (83.2 % RIV4 vs. 66.8 % SD-IIV4; P < 0 001. Among older adults, receipt of RIV4 was signiﬁcantly associated with having a high risk condition (91.1 % RIV4 vs. 78.4 % SD-IIV4 P < 0 001. In a second scenario older adults receiving SD-IIV4 were compared with those receiving RIV4, HD-IIV4, or Adj-IV , because these latter two ‘‘enhanced” vaccines are now recommended for",
      "metadata": {
        "score": 0.9956947565078735,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006318092346191406,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "54147998",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        187.74337768554688,
        349.58074951171875,
        1616.2252197265625,
        821.6270141601562
      ],
      "text": "",
      "metadata": {
        "score": 0.9912633895874023,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "f681d51a",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        1700.5277099609375,
        353.1723327636719,
        3105.30810546875,
        591.703125
      ],
      "text": "",
      "metadata": {
        "score": 0.9879685640335083,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "16c82a45",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        110.04927062988281,
        4097.65087890625,
        3117.232666015625,
        4209.28515625
      ],
      "text": "R. K. Zimmerman, M. Patricia No walk, K. Dauer et al. Vaccine 41 (2023) 5134-5140",
      "metadata": {
        "score": 0.9872791767120361,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0001709461212158203,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "ac70eb65",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        197.77650451660156,
        2645.0302734375,
        1604.172119140625,
        2805.849853515625
      ],
      "text": "3. Results Th t t l b f i ﬂ t t lt i ti t",
      "metadata": {
        "score": 0.9821975231170654,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00004315376281738281,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "9f13a8a2",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        197.97254943847656,
        1624.276123046875,
        431.4623718261719,
        1699.921142578125
      ],
      "text": "analyses a (80 %), just",
      "metadata": {
        "score": 0.9956424236297607,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00004291534423828125,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "912bbfa5",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        2596.8388671875,
        246.7254638671875,
        3115.238037109375,
        321.0141296386719
      ],
      "text": "vaccine (RIV4), standard dose",
      "metadata": {
        "score": 0.5779748558998108,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": false,
          "processing_time": 0.00007796287536621094
        }
      }
    },
    {
      "id": "dec8b461",
      "page_index": 2,
      "role": "Text",
      "bbox": [
        204.40982055664062,
        1479.494140625,
        833.033935546875,
        1541.1826171875
      ],
      "text": "",
      "metadata": {
        "score": 0.3491898775100708,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "683260d6",
      "page_index": 2,
      "role": "Title",
      "bbox": [
        183.25103759765625,
        249.0458984375,
        1073.06005859375,
        317.10369873046875
      ],
      "text": "Fig. 1. Flow chart for primary analyses. The prima d i l i ﬂ i ( ) d h",
      "metadata": {
        "score": 0.22126039862632751,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00009298324584960938,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "5b925a10",
      "page_index": 3,
      "role": "Figure",
      "bbox": [
        415.6159362792969,
        311.96685791015625,
        2865.8515625,
        1549.7667236328125
      ],
      "text": "[FIGURE 1 - See figure_p4_5b925a10.png]",
      "image_path": "figures/figure_p4_5b925a10.png",
      "metadata": {
        "score": 0.9985653758049011,
        "detection_dpi": 400
      }
    },
    {
      "id": "af80ee6a",
      "page_index": 3,
      "role": "Table",
      "bbox": [
        216.453857421875,
        1932.0751953125,
        3115.081787109375,
        2609.368896484375
      ],
      "text": "[TABLE 4 - See table_p4_af80ee6a.png]",
      "image_path": "figures/table_p4_af80ee6a.png",
      "metadata": {
        "score": 0.9949997663497925,
        "detection_dpi": 400
      }
    },
    {
      "id": "dce1470c",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1687.40771484375,
        2996.5556640625,
        3115.266845703125,
        4104.518310546875
      ],
      "text": "",
      "metadata": {
        "score": 0.9900246858596802,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "5a275730",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        189.09657287597656,
        3058.043212890625,
        1615.44580078125,
        3591.42333984375
      ],
      "text": "",
      "metadata": {
        "score": 0.9952172040939331,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "7741d5a3",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        205.91085815429688,
        3748.1083984375,
        1617.2470703125,
        4120.96923828125
      ],
      "text": "R. K. Zimmerman, M. Patricia No walk, K. Dauer et al.",
      "metadata": {
        "score": 0.989359974861145,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0001590251922607422,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "46b700dd",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        195.77923583984375,
        1563.98779296875,
        3113.666015625,
        1726.2537841796875
      ],
      "text": "b RIV4: Flublok. c SD-IIV4: A uri a, Fluarix, FluLaval, Standard Dose Flu zone and FlucelVax.",
      "metadata": {
        "score": 0.9939186573028564,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00016999244689941406,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "3512280d",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        178.0096893310547,
        2633.2861328125,
        2195.40185546875,
        2778.141845703125
      ],
      "text": "quad rival ent inﬂuenza vaccine (SD-IIV4), high dose quad rival ent inﬂuenza vaccine (HD-IIV4), adjuvanted inﬂuenza v otherwise excluded.",
      "metadata": {
        "score": 0.9689196348190308,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0004506111145019531,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d292f79a",
      "page_index": 3,
      "role": "Title",
      "bbox": [
        198.55897521972656,
        3636.33349609375,
        507.41387939453125,
        3715.037841796875
      ],
      "text": "",
      "metadata": {
        "score": 0.9970023036003113,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "b118e9eb",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        1694.9298095703125,
        2862.66259765625,
        3108.26904296875,
        2959.44580078125
      ],
      "text": "",
      "metadata": {
        "score": 0.9685475826263428,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "0f972057",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        202.65476989746094,
        2866.473388671875,
        1610.9613037109375,
        3031.13427734375
      ],
      "text": "",
      "metadata": {
        "score": 0.955023467540741,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "8d99b5d7",
      "page_index": 3,
      "role": "Text",
      "bbox": [
        71.3418197631836,
        1858.0654296875,
        3061.46826171875,
        1926.362548828125
      ],
      "text": "\u000165 years 7,694 (53) 1,930 (58) 213 (22) Inﬂuenza case, ref. = non case, n (%) 1,803 (12) 291 (9) 114 (12) 0.005",
      "metadata": {
        "score": 0.9431441426277161,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00015687942504882812,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "59cf0f3a",
      "page_index": 4,
      "role": "Table",
      "bbox": [
        207.56690979003906,
        524.2344970703125,
        3150.543701171875,
        1353.1671142578125
      ],
      "text": "[TABLE 3 - See table_p5_59cf0f3a.png]",
      "image_path": "figures/table_p5_59cf0f3a.png",
      "metadata": {
        "score": 0.9914271831512451,
        "detection_dpi": 400
      }
    },
    {
      "id": "f309d921",
      "page_index": 4,
      "role": "Table",
      "bbox": [
        210.28390502929688,
        2952.1787109375,
        3135.147705078125,
        3526.56298828125
      ],
      "text": "[TABLE 9 - See table_p5_f309d921.png]",
      "image_path": "figures/table_p5_f309d921.png",
      "metadata": {
        "score": 0.9906010627746582,
        "detection_dpi": 400
      }
    },
    {
      "id": "9a469613",
      "page_index": 4,
      "role": "Table",
      "bbox": [
        237.73974609375,
        1936.757080078125,
        3138.505859375,
        2445.631591796875
      ],
      "text": "[TABLE 6 - See table_p5_9a469613.png]",
      "image_path": "figures/table_p5_9a469613.png",
      "metadata": {
        "score": 0.9889547824859619,
        "detection_dpi": 400
      }
    },
    {
      "id": "3f7014f9",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        208.1142578125,
        3595.577880859375,
        1602.3697509765625,
        4208.25341796875
      ],
      "text": "Table 2 Vaccine effectiveness (VE) of recombinant quad rival ent inﬂuenza vaccine (RIV4) an propensity scores and inverse probability weighting (IPW). Group Adjusted RIV4a VE compared to no vaccination Adjusted SD-IIV4b VE compared to no vaccination R. K. Zimmerman, M. Patricia No walk, K. Dauer et al.",
      "metadata": {
        "score": 0.9939411878585815,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006971359252929688,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "09751f21",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1693.6690673828125,
        3596.2451171875,
        3110.97509765625,
        3936.833984375
      ],
      "text": "lat ive vaccine effectiveness of RIV4 mpa red to SD-IIV4, % (95 % CI) djusted using a priori riablesc Adjusted using propensity scored Adjusted using IPW",
      "metadata": {
        "score": 0.9925835132598877,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0002968311309814453,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "1799b1b2",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        1693.273681640625,
        3965.14111328125,
        3109.78125,
        4211.75537109375
      ],
      "text": "and ard dose quad rival ent inﬂuenza vaccine (SD-IIV4) and relative VE of RIV4 using Vaccine 41 (2023) 5134-5140",
      "metadata": {
        "score": 0.9917895793914795,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0002579689025878906,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "985ff648",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        215.5356903076172,
        2830.765869140625,
        3091.7861328125,
        2946.574462890625
      ],
      "text": "Multivariable logistic regression model adjusted for age, race, sex, season, and high risk conditions, except that the stratiﬁed variable is not included as an adjustment in its own analysis. d Propensity score: Generalized Boosted Regression Method was used to calculate the propensity score using TWANG (Toolkit for Weighting and Analysis of Non equivalent",
      "metadata": {
        "score": 0.9902682900428772,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006330013275146484,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "32de05ea",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        218.49447631835938,
        1821.116943359375,
        3103.4375,
        1926.3177490234375
      ],
      "text": "a SD-IIV4: A uri a, Fluarix, FluLaval, SD Flu zone and FlucelVax. b For difference between those receiving RIV4 and those receiving SD-IIV4. c RIV4: Flublok; HD-IIV4: High dose Flu zone; Adj-IV: FluAd",
      "metadata": {
        "score": 0.9918882250785828,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00026416778564453125,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "2482ab49",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        243.51736450195312,
        1360.20654296875,
        3114.849365234375,
        1635.0543212890625
      ],
      "text": "able 4 djusted vaccine effectiveness (VE) of recombinant quad rival ent inﬂuenza vaccine (RIV4), standard dose quad rival ent inﬂuenza vaccine (SD-IIV4), and RIV4 + high dose uadrivalent inﬂuenza vaccine (HD-IIV4) + adjuvanted inﬂuenza vaccine (Adj-IV), compared with no vaccination, by age group. 18–64 years \u000165 years G RIV4 SD IIV4 RIV4 RIV4 HD IIV4 Adj IV SD IIV4",
      "metadata": {
        "score": 0.9383675456047058,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0006120204925537109,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d55941a2",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        38.621585845947266,
        406.1799621582031,
        3125.353515625,
        516.1522827148438
      ],
      "text": "g \u0001 y ﬁrmed ILI nor culture positive ILI. For those 50–64 years, rVE was sign i cant against RT-PCR ILI (42 %; 95 % CI = 15, 61) and against y p y 10 codes and not speciﬁcally on laboratory conﬁrmed inﬂuenza. In a 2019 editorial, Flannery and Fry stated, ‘‘Evidence to in form",
      "metadata": {
        "score": 0.9821889996528625,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0004363059997558594,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "68411260",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        237.77627563476562,
        2473.091064453125,
        1794.1875,
        2672.3994140625
      ],
      "text": "able 3 har act eris tics of participants by age group and vaccine received including recombinant quad riva V4), high dose quad rival ent inﬂuenza vaccine (HD-IIV4) and adjuvanted inﬂuenza vaccine (Adj",
      "metadata": {
        "score": 0.9789759516716003,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0004849433898925781,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "d2bec6d7",
      "page_index": 4,
      "role": "Text",
      "bbox": [
        194.0700225830078,
        249.47268676757812,
        1068.1556396484375,
        314.48846435546875
      ],
      "text": "was a retrospective cohort study of Medic of age and above in 2019-2020 by I zur iet",
      "metadata": {
        "score": 0.37342482805252075,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0001380443572998047,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "be45d0a5",
      "page_index": 5,
      "role": "Table",
      "bbox": [
        355.6662292480469,
        371.433837890625,
        1514.6693115234375,
        4240.431640625
      ],
      "text": "[TABLE 1 - See table_p6_be45d0a5.png]",
      "image_path": "figures/table_p6_be45d0a5.png",
      "metadata": {
        "score": 0.9726459383964539,
        "detection_dpi": 400
      }
    },
    {
      "id": "1f1bf515",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1694.9571533203125,
        755.2674560546875,
        3101.456298828125,
        3108.6943359375
      ],
      "text": "ond, as an integrated healthcare system, its EMR is robust, with regular uploads of vaccination data from the state immunization registry. In addition, we veriﬁed vaccination status through the state registry with a speciﬁc data request. In previous research, we have demonstrated that registry data are a reasonable source for inﬂuenza vaccination data [18]. As a result, we have conﬁdence that inﬂuenza vaccinations are captured accurately in the EMR. If vaccinations were not captured in the EMR or state registry, they were classiﬁed as unvaccinated. While this class i cation would likely introduce bias into VE estimates [16], it would likely not bias rVE estimates, as there is no reason to believe that any vaccine is preferentially included or excluded from reporting to the state reg- istry. This study excluded subjects with immuno suppress ive con- ditions or those receiving immuno suppress ive therapy whose response to vaccines is limited. Because data focused on hospital- ized patients, there may have been milder cases that did not require medical care and were not captured in the EMR, thus did not contribute to these estimates. Adding measures of severity of illness into the model would improve the accuracy of the VE esti- mates, however, these measures were not available. The differ- ences in severity are likely narrower given that all were sufﬁciently ill to require hospitalization, thus mitigating the need for such an adjustment. It is possible that there may have been selection bias among those who received inﬂuenza virus testing, for example, clinicians may preferentially test those who are unvaccinated against inﬂuenza thus increasing the proportion of unvaccinated cases. Based on a previous study among patients in this health system that found no increase in testing based on vac- cination status [19], we feel con dent that this is not a concern. While a relatively large cohort of adults is included in this study, the sample size of SD-IIV4 recipients may have been inadequate to detect meaningful rVE estimates for speciﬁc subgroups. These data should be viewed in the context of the seasons for which data were collected. These seasons were ‘‘typical” in that inﬂuenza began to increase in November, peaking in January and February both seasons, and numbers of inﬂuenza-related deaths were 28 000 in 2018-2019 and 25 000 in 2019-2020. These sea- sons were atypical in that virtually no inﬂuenza B circulated in 2018-2019 but there were both A (H1N1) and A (H3N2) peaks and in 2019-2020, inﬂuenza B circulated early followed by A (H1N1) in contrast to typical seasons in which the inﬂuenza A d h ﬂ [ ] h h h",
      "metadata": {
        "score": 0.9577734470367432,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.003915071487426758,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "f6728c2d",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1693.11865234375,
        3127.677490234375,
        3095.42919921875,
        3890.26708984375
      ],
      "text": "all adults, and supports its superior effectiveness over SD IIV4 for adults 18–64 years of age. 4.1. Strengths and limitations This study has several strengths and limitations. Firstly, the demographics of the study population were similar to those of the Allegheny County general population of adults in which 79 % are white and 51 % are female [17], thus contributing to generaliz- ability. Moreover, the health system includes urban tertiary and quaternary care hospitals as well as suburban and rural commu- nity hospitals. It has a 60 % market share of all hospital beds in the county and accepts patients with all insurance products. Sec- ond as an integrated healthcare s stem its EMR is robust ith",
      "metadata": {
        "score": 0.9940354824066162,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0009729862213134766,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "baf7bc01",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        1689.2864990234375,
        3963.316162109375,
        2036.9332275390625,
        4041.122314453125
      ],
      "text": "ate potential im adds to the evid",
      "metadata": {
        "score": 0.9966855645179749,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00007295608520507812,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "cf1f9ec3",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        1690.9671630859375,
        672.243896484375,
        2311.875,
        750.7525634765625
      ],
      "text": "wave precedes the inﬂuenza circulation of A (H3N2) may",
      "metadata": {
        "score": 0.9895023107528687,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00013303756713867188,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "fe2454d6",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1685.4368896484375,
        352.0729064941406,
        3107.424072265625,
        621.35302734375
      ],
      "text": "because it is not subject to mutations to the A (H3N2) glycosylation binding site that reduce the effectiveness of egg based vaccines. 5. Conclusions",
      "metadata": {
        "score": 0.9398762583732605,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0003540515899658203,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "6b73ab8b",
      "page_index": 5,
      "role": "Text",
      "bbox": [
        1708.271484375,
        4077.451416015625,
        3115.638427734375,
        4216.38232421875
      ],
      "text": "Vaccine 41 (2023) 5134-5140",
      "metadata": {
        "score": 0.9234251379966736,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00007796287536621094,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "44229d05",
      "page_index": 5,
      "role": "Title",
      "bbox": [
        2598.69287109375,
        246.57489013671875,
        3114.859375,
        321.08197021484375
      ],
      "text": "ntly effective among all t li ti d i th",
      "metadata": {
        "score": 0.4051310420036316,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00004696846008300781,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "8eacadd3",
      "page_index": 6,
      "role": "List",
      "bbox": [
        1658.24658203125,
        328.2525329589844,
        3144.4755859375,
        3109.78369140625
      ],
      "text": "beneﬁts of cell culture isolation and manufacturing. The rap Adv Vacc Immunoth 2020 8 1 10. https doi org 10 1177-2515135520908121. [10] I zur iet a HS, Lu M, Kel man J, Lu Y, Linda as A, Loc J, et al. Comparative effectiveness of inﬂuenza vaccines among US Medicare bene cia ries ages 65 years and older during the 2019-2020 season. Clin Infect Dis 2021 73 11: e4251–9. [11] Dunkle LM, Izikson R, Patria rca P, Goldenthal KL, Muse D, Callahan J, et al. Efﬁcacy of recombinant inﬂuenza vaccine in adults 50 years of age or older. N Engl J Med 2017 376 25 2427 36. [12] Centers for Disease Control and Prevention. People at Higher Risk of Flu Complications. Updated 9 6 2022. Accessed 12 19 2022, https www. cdc.gov/ﬂu/highrisk/index.htm. [13] Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 23 Inﬂuenza Season. Morbidity and Mortality Weekly Report (MMWR). August 26, 2022 71 (1 1 28. https://doi.org/10.15585/mmwr.rr7101a1. [14] Centers for Disease Control and Prevention. Archived: Estimated Inﬂuenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States — 2018-2019 inﬂuenza season. Updated 9 30 2021. Accessed 2 7 2023, https:// www.cdc.gov/ﬂu/about/burden/2018-2019/archive-09292021.html#:\u0004: text=The%20overall%20burden%20of%20inﬂuenza, hospitalizations%2C%20and %2028%2C000%20ﬂu%20deaths. [15] Centers for Disease Control and Prevention. Estimated Flu-Related Illnesses, Medical visits, Hospitalizations, and Deaths in the United States — 2019-2020 Flu Season. Updated 10 7 2022. Accessed 2 7 2023, https://www.cdc.gov/ﬂu/ about burden 2019-2020 html. [16] Flannery B, Fry AM. Comparing inﬂuenza vaccine types: the path toward improved inﬂuenza vaccine strategies. Oxford University Press US; 2019. p. 1237 9. [17] United States CensusBureau. Quick Facts Allegheny County, Pennsylvania. Accessed 2 7 2023, https www census gov quick facts allegheny county pennsylvania. [18] No walk MP, D’Agostino HEA, Zimmerman RK, Saul SG, Susick M, Ravi ott a JM, et al. Agreement among sources of adult inﬂuenza vaccination in the age of immunization information systems. Vaccine 2021 39 47 6829 36. [19] Bala sub raman i GK, Saul S, No walk MP, Middleton DB, Ferdinands JM, Zimmerman RK. Does inﬂuenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias. Hum Vaccin Immunother 2019 15 1 91 6.",
      "metadata": {
        "score": 0.9423152208328247,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.005775928497314453,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "106dfe46",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        202.39373779296875,
        1057.3245849609375,
        1609.1226806640625,
        1489.05224609375
      ],
      "text": "Infect Dis 2014 58 3 319 27. https://doi.org/10.1093/Cid/Cit736. [2] McLean HQ, Thompson MG, Sunda ram ME, Kieke BA, Gag lani M, Mur thy K, et al. Inﬂuenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type. J Infect Dis 2015 211 10 1529 40. https://doi.org/10.1093/infdis/jiu647.",
      "metadata": {
        "score": 0.9865603446960449,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0007419586181640625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "737bd547",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        207.23780822753906,
        2237.205810546875,
        1617.964111328125,
        2623.5615234375
      ],
      "text": "views of the authors and not Sanoﬁ. Data Deidentiﬁed data may be made available upon request. Author contributions",
      "metadata": {
        "score": 0.9789491295814514,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.000186920166015625,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "e6796426",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        198.58033752441406,
        353.6547546386719,
        1626.482177734375,
        664.1068725585938
      ],
      "text": "",
      "metadata": {
        "score": 0.9755163788795471,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "bd896c2d",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        198.2258758544922,
        1531.2353515625,
        657.251953125,
        1610.4847412109375
      ],
      "text": "[1] Ohmit SE, Thompson Inﬂuenza vaccine effe each circulating virus",
      "metadata": {
        "score": 0.9974043965339661,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00011205673217773438,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "b12c3c25",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        190.39671325683594,
        951.0720825195312,
        994.5106201171875,
        1027.1195068359375
      ],
      "text": "",
      "metadata": {
        "score": 0.9918763637542725,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "23efd25c",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        198.15394592285156,
        2131.89794921875,
        692.3211669921875,
        2209.4716796875
      ],
      "text": "RKZ conceived the st",
      "metadata": {
        "score": 0.9942732453346252,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": false,
          "processing_time": 0.00006318092346191406
        }
      }
    },
    {
      "id": "a2499b36",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        193.95518493652344,
        716.8428344726562,
        581.2420654296875,
        796.3131713867188
      ],
      "text": "",
      "metadata": {
        "score": 0.9929551482200623,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "09be1973",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        197.93197631835938,
        1646.82275390625,
        1606.4942626953125,
        1841.6683349609375
      ],
      "text": "the study, procure funding and edited the manuscript. References",
      "metadata": {
        "score": 0.9646224975585938,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0001518726348876953,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "1a8f97fc",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        197.67230224609375,
        2657.233154296875,
        463.0515441894531,
        2728.11376953125
      ],
      "text": "This work initiated gra",
      "metadata": {
        "score": 0.9841676354408264,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.000051021575927734375,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "48f2113c",
      "page_index": 6,
      "role": "List",
      "bbox": [
        221.12118530273438,
        2756.75537109375,
        1623.5665283203125,
        3137.52685546875
      ],
      "text": "received investigator initiated grant funding from Sano for this project. Drs. No walk and Bala sub raman i, have grant funding from Merck & Co., Inc. for an unrelated project. Ms. Dauer and Mr. Clarke have no conﬂicts to report. Acknowledgements",
      "metadata": {
        "score": 0.9251576662063599,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.0005462169647216797,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "bbab84e8",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        246.64144897460938,
        2006.250732421875,
        1454.521484375,
        2080.87109375
      ],
      "text": "nd edited the manuscript. GKB oversaw the data preparati nalyses and edited the manuscript MPN drafted and edit",
      "metadata": {
        "score": 0.9331190586090088,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.00021696090698242188,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "421d2a21",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        196.86325073242188,
        1888.9517822265625,
        318.6426086425781,
        1967.094970703125
      ],
      "text": "manu procu",
      "metadata": {
        "score": 0.8541672825813293,
        "detection_dpi": 400,
        "extraction_confidence": 1.0,
        "extraction": {
          "method": "pymupdf",
          "scale_factor": 0.18,
          "text_modified": true,
          "processing_time": 0.000016927719116210938,
          "processors_applied": [
            "spacing_fix"
          ]
        }
      }
    },
    {
      "id": "22ac967f",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        2596.64111328125,
        247.27359008789062,
        3112.5771484375,
        321.1121520996094
      ],
      "text": "",
      "metadata": {
        "score": 0.7648159861564636,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "e0bd2156",
      "page_index": 6,
      "role": "Text",
      "bbox": [
        263.5187683105469,
        831.2192993164062,
        1400.790771484375,
        909.4758911132812
      ],
      "text": "",
      "metadata": {
        "score": 0.6897035241127014,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    },
    {
      "id": "7c3aa7e5",
      "page_index": 6,
      "role": "Title",
      "bbox": [
        183.92581176757812,
        249.13668823242188,
        1075.611572265625,
        317.6626892089844
      ],
      "text": "",
      "metadata": {
        "score": 0.4018542468547821,
        "detection_dpi": 400,
        "extraction_status": "empty"
      }
    }
  ],
  "reading_order": [
    [
      "a1cb3909",
      "b4e28b86",
      "055177cc",
      "ed8bd334",
      "80bc60b3",
      "308766f1",
      "532a4b79",
      "6ce8cb81",
      "60d1eb27",
      "68b01457",
      "6bf7c6eb",
      "697b239f",
      "8fc45971"
    ],
    [
      "af96fe48",
      "206246cf",
      "855b3df8",
      "79cbb5c4",
      "46cc96cd",
      "8467ff67",
      "e8131896",
      "a788eecc",
      "7345b0ed",
      "4958fbac",
      "7332f007",
      "22eb7506",
      "8737e17e",
      "ea78cbe6"
    ],
    [
      "683260d6",
      "54147998",
      "c20bb765",
      "dec8b461",
      "9f13a8a2",
      "caa70ae4",
      "ac70eb65",
      "41870911",
      "912bbfa5",
      "f681d51a",
      "566c806c",
      "29672a8c",
      "f8bde505",
      "16c82a45"
    ],
    [
      "5b925a10",
      "46b700dd",
      "8d99b5d7",
      "af80ee6a",
      "3512280d",
      "0f972057",
      "5a275730",
      "d292f79a",
      "7741d5a3",
      "b118e9eb",
      "dce1470c"
    ],
    [
      "d2bec6d7",
      "d55941a2",
      "59cf0f3a",
      "2482ab49",
      "32de05ea",
      "9a469613",
      "68411260",
      "985ff648",
      "f309d921",
      "3f7014f9",
      "09751f21",
      "1799b1b2"
    ],
    [
      "be45d0a5",
      "44229d05",
      "fe2454d6",
      "cf1f9ec3",
      "1f1bf515",
      "f6728c2d",
      "baf7bc01",
      "6b73ab8b"
    ],
    [
      "7c3aa7e5",
      "e6796426",
      "a2499b36",
      "e0bd2156",
      "b12c3c25",
      "106dfe46",
      "bd896c2d",
      "09be1973",
      "421d2a21",
      "bbab84e8",
      "23efd25c",
      "737bd547",
      "1a8f97fc",
      "48f2113c",
      "22ac967f",
      "8eacadd3"
    ]
  ],
  "metadata": {
    "detection_dpi": 400,
    "total_pages": 7,
    "merge_settings": {
      "merge_overlapping": true,
      "merge_threshold": 0.3,
      "confidence_weight": 0.7,
      "area_weight": 0.3
    },
    "extraction": {
      "text_blocks": 60,
      "figure_blocks": 8,
      "figures_dir": "data/cache/Zimmerman_et_al.__2023_/extracted/figures"
    }
  }
}